Published in J Clin Microbiol on December 01, 1999
Quantitative real-time PCR for Porphyromonas gingivalis and total bacteria. J Clin Microbiol (2000) 3.03
Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum (2010) 2.53
Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology. Ann Rheum Dis (2014) 2.32
The oral microbial consortium's interaction with the periodontal innate defense system. DNA Cell Biol (2009) 1.41
Comparative whole-genome analysis of virulent and avirulent strains of Porphyromonas gingivalis. J Bacteriol (2004) 1.36
Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun (2012) 1.27
Association of Bacteroides forsythus and a novel Bacteroides phylotype with periodontitis. J Clin Microbiol (2002) 1.21
Porphyromonas gingivalis RgpA-Kgp proteinase-adhesin complexes penetrate gingival tissue and induce proinflammatory cytokines or apoptosis in a concentration-dependent manner. Infect Immun (2008) 1.18
Culture-independent identification of periodontitis-associated Porphyromonas and Tannerella populations by targeted molecular analysis. J Clin Microbiol (2004) 1.08
Porphyromonas gingivalis strain diversity. J Clin Microbiol (2009) 1.08
Gingipains from Porphyromonas gingivalis W83 synergistically disrupt endothelial cell adhesion and can induce caspase-independent apoptosis. Infect Immun (2006) 1.03
Sequence diversity and antigenic variation at the rag locus of Porphyromonas gingivalis. Infect Immun (2005) 1.03
Evidence of recombination in Porphyromonas gingivalis and random distribution of putative virulence markers. Infect Immun (2001) 1.02
Expression of peptidylarginine deiminase from Porphyromonas gingivalis in Escherichia coli: enzyme purification and characterization. Arch Biochem Biophys (2009) 1.01
Microbiology and treatment of acute apical abscesses. Clin Microbiol Rev (2013) 0.96
Invasive differences among Porphyromonas gingivalis strains from healthy and diseased periodontal sites. J Periodontal Res (2008) 0.94
Flow cytometric analysis of adherence of Porphyromonas gingivalis to oral epithelial cells. Infect Immun (2007) 0.94
Streptococcus cristatus ArcA interferes with Porphyromonas gingivalis pathogenicity in mice. J Periodontal Res (2012) 0.88
Genotype is an important determinant factor of host susceptibility to periodontitis in the Collaborative Cross and inbred mouse populations. BMC Genet (2013) 0.88
Phylogeny of Porphyromonas gingivalis by ribosomal intergenic spacer region analysis. J Clin Microbiol (2000) 0.84
Distribution of Porphyromonas gingivalis biotypes defined by alleles of the kgp (Lys-gingipain) gene. J Clin Microbiol (2004) 0.83
Porphyromonas gingivalis virulence in a Drosophila melanogaster model. Infect Immun (2010) 0.81
Invasion of Porphyromonas gingivalis strains into vascular cells and tissue. J Oral Microbiol (2015) 0.80
The rag locus of Porphyromonas gingivalis might arise from Bacteroides via horizontal gene transfer. Eur J Clin Microbiol Infect Dis (2010) 0.80
Major neutrophil functions subverted by Porphyromonas gingivalis. J Oral Microbiol (2016) 0.79
The unique hmuY gene sequence as a specific marker of Porphyromonas gingivalis. PLoS One (2013) 0.78
Evolutionary Divergence of Aggregatibacter actinomycetemcomitans. J Dent Res (2015) 0.77
GM-CSF and uPA are required for Porphyromonas gingivalis-induced alveolar bone loss in a mouse periodontitis model. Immunol Cell Biol (2015) 0.77
Unprimed, M1 and M2 Macrophages Differentially Interact with Porphyromonas gingivalis. PLoS One (2016) 0.76
Porphyromonas gingivalis Uses Specific Domain Rearrangements and Allelic Exchange to Generate Diversity in Surface Virulence Factors. Front Microbiol (2017) 0.75
Zebrafish as a new model to study effects of periodontal pathogens on cardiovascular diseases. Sci Rep (2016) 0.75
PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol (1999) 5.58
Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol (1994) 3.20
Analysis of 16S-23S rRNA intergenic spacer regions of Vibrio cholerae and Vibrio mimicus. Appl Environ Microbiol (1999) 2.23
A novel mouse model to study the virulence of and host response to Porphyromonas (Bacteroides) gingivalis. Infect Immun (1991) 2.07
Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol (1998) 2.06
Subgingival microbiota in healthy, well-maintained elder and periodontitis subjects. J Clin Periodontol (1998) 2.06
Heterogeneity of virulence among strains of Bacteroides gingivalis. J Periodontal Res (1989) 1.99
Comparison of DNA probe and ELISA microbial analysis methods and their association with adult periodontitis. J Periodontol (1994) 1.73
Clinical criteria for the definition of "established periodontitis". J Periodontol (1992) 1.65
Genetic structure of populations of Porphyromonas gingivalis associated with periodontitis and other oral infections. Infect Immun (1993) 1.58
Distribution of Porphyromonas gingivalis strains with fimA genotypes in periodontitis patients. J Clin Microbiol (1999) 1.58
Virulence of six capsular serotypes of Porphyromonas gingivalis in a mouse model. Oral Microbiol Immunol (1998) 1.54
Age and prevalence of Porphyromonas gingivalis in children. J Clin Microbiol (1996) 1.50
Differences in virulence within the species Bacteroides gingivalis. Antonie Van Leeuwenhoek (1987) 1.36
Human and animal serotypes of Bacteroides gingivalis defined by crossed immunoelectrophoresis. Infect Immun (1986) 1.36
Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol (1997) 1.36
RFLP of rRNA genes and sequencing of the 16S-23S rDNA intergenic spacer region of ammonia-oxidizing bacteria: a phylogenetic approach. Int J Syst Bacteriol (1999) 1.32
Risk indicators for periodontal disease in a racially diverse urban population. J Clin Periodontol (1996) 1.30
Effect of host responses on the pathogenicity of strains of Porphyromonas gingivalis. Oral Microbiol Immunol (1996) 1.28
Subgingival microbiota in adult Chinese: prevalence and relation to periodontal disease progression. J Periodontol (1997) 1.24
Comparative virulence of periodontopathogens in a mouse abscess model. Oral Dis (1995) 1.24
Comparison of three molecular typing methods in studies of transmission of Porphyromonas gingivalis. J Med Microbiol (1993) 1.21
Periodontopathic potential of two strains of Porphyromonas gingivalis in gnotobiotic rats. Arch Oral Biol (1992) 1.18
Identification of Porphyromonas gingivalis strains by heteroduplex analysis and detection of multiple strains. J Clin Microbiol (1999) 1.15
The natural history of periodontal disease. The correlation of selected microbiological parameters with disease severity in Sri Lankan tea workers. J Clin Periodontol (1995) 1.13
Application of polymerase chain reaction with arbitrary primer (AP-PCR) to strain identification of Porphyromonas (Bacteroides) gingivalis. FEMS Microbiol Lett (1992) 1.09
The effect of periodontal treatment on periodontal bacteria on the oral mucous membranes. J Periodontol (1996) 1.09
The use of genomic DNA fingerprinting in studies of the epidemiology of bacteria in periodontitis. J Clin Periodontol (1991) 1.07
Sequencing of the ribosomal intergenic spacer region for strain identification of Porphyromonas gingivalis. J Clin Microbiol (1999) 1.03
Strain identification of Actinobacillus actinomycetemcomitans using the polymerase chain reaction. Oral Microbiol Immunol (1992) 1.01
Source of suspected periodontal pathogens re-emerging after periodontal treatment. J Clin Periodontol (1996) 0.99
Characterization of hemolytic bacteria in subgingival plaque. J Periodontal Res (1993) 0.87
[Serological classification of Bacteroides gingivalis and purification of group specific antigens]. Shika Kiso Igakkai Zasshi (1989) 0.84
New bacterial species associated with chronic periodontitis. J Dent Res (2003) 4.03
Quantitative real-time PCR for Porphyromonas gingivalis and total bacteria. J Clin Microbiol (2000) 3.03
Depression as an antecedent to heart disease among women and men in the NHANES I study. National Health and Nutrition Examination Survey. Arch Intern Med (2000) 2.82
Dihydrofolate reductase gene expression in cultured mouse cells is regulated by transcript stabilization in the nucleus. J Cell Biol (1984) 2.12
Prevalence of Porphyromonas gingivalis and periodontal health status. J Clin Microbiol (1998) 2.06
Analysis of the mouse dhfr promoter region: existence of a divergently transcribed gene. Mol Cell Biol (1985) 2.02
Misclassification of smoking status among Southeast Asian adult immigrants. Am J Respir Crit Care Med (1995) 1.82
Control of dihydrofolate reductase messenger ribonucleic acid production. Mol Cell Biol (1981) 1.82
Factors influencing the one-year mortality of dilated cardiomyopathy. Am J Cardiol (1984) 1.57
Transcription of the mouse dihydrofolate reductase gene proceeds unabated through seven polyadenylation sites and terminates near a region of repeated DNA. Mol Cell Biol (1984) 1.55
A bivariate survival model with modified gamma frailty for assessing the impact of interventions. Stat Med (1993) 1.55
Age and prevalence of Porphyromonas gingivalis in children. J Clin Microbiol (1996) 1.50
Control of cellular gene expression during adenovirus infection: induction and shut-off of dihydrofolate reductase gene expression by adenovirus type 2. Mol Cell Biol (1983) 1.47
Acquisition and colonization stability of Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in children. J Clin Microbiol (2000) 1.38
AC/A ratio, age, and refractive error in children. Invest Ophthalmol Vis Sci (2000) 1.28
Economic differentials in cancer survival: a multivariate analysis. J Chronic Dis (1984) 1.18
Identification of Porphyromonas gingivalis strains by heteroduplex analysis and detection of multiple strains. J Clin Microbiol (1999) 1.15
Ocular predictors of the onset of juvenile myopia. Invest Ophthalmol Vis Sci (1999) 1.13
Crystal structures of human factor Xa complexed with potent inhibitors. J Med Chem (2000) 1.11
Program description: a hospitalist-run, medical short-stay unit in a teaching hospital. CMAJ (2000) 1.10
Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Int J Radiat Oncol Biol Phys (2000) 1.08
Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of either sodium borocaptate or boronophenylalanine with or without blood-brain barrier disruption. Cancer Res (1997) 1.07
Sequencing of the ribosomal intergenic spacer region for strain identification of Porphyromonas gingivalis. J Clin Microbiol (1999) 1.03
Strain identification of Actinobacillus actinomycetemcomitans using the polymerase chain reaction. Oral Microbiol Immunol (1992) 1.01
Filifactor alocis interactions with gingival epithelial cells. Mol Oral Microbiol (2011) 0.98
Boron neutron capture therapy of a rat glioma. Neurosurgery (1990) 0.98
Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption. Neurosurgery (1996) 0.95
Platelet-mediated bleeding caused by broad-spectrum penicillins. J Infect Dis (1987) 0.93
Supplemental dietary biotin for prevention of lesions associated with aseptic subclinical laminitis (pododermatitis aseptica diffusa) in primiparous cows. Am J Vet Res (1998) 0.91
Concordance of Porphyromonas gingivalis colonization in families. J Clin Microbiol (1997) 0.89
Preparing the "Ground War" against tobacco among Chinese Americans in New York City: baseline data. Asian Am Pac Isl J Health (2001) 0.89
TRAIL-mediated apoptosis in malignant glioma cells is augmented by celecoxib through proteasomal degradation of survivin. Neurosci Lett (2008) 0.87
Estimation of reference ranges: how many subjects are needed? Clin Chem (1992) 0.87
The effects of ultraviolet radiation on the moderate halophile Halomonas elongata and the extreme halophile Halobacterium salinarum. Can J Microbiol (2000) 0.87
Boron neutron capture therapy of intracerebral melanoma using boronophenylalanine as a capture agent. Cancer Res (1993) 0.87
A cross-sectional case control study of work-related injuries among Ohio farmers. Am J Ind Med (1998) 0.86
Phylogeny of Porphyromonas gingivalis by ribosomal intergenic spacer region analysis. J Clin Microbiol (2000) 0.84
Bounds on net survival probabilities for dependent competing risks. Biometrics (1988) 0.83
Subclinical laminitis in dairy cows: use of severity of hoof lesions to rank and evaluate herds. Vet Rec (1999) 0.82
An analysis of the determinants of exercise performance in congestive heart failure. Am Heart J (1987) 0.82
A comparison of several methods of estimating the survival function when there is extreme right censoring. Biometrics (1985) 0.81
Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate. Biochem Pharmacol (1991) 0.80
A nude rat model for neutron capture therapy of human intracerebral melanoma. Int J Radiat Oncol Biol Phys (1994) 0.80
Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine. J Neurooncol (1997) 0.80
Biological and environmental risk for poor developmental outcome of young children. Am J Ment Retard (1993) 0.79
Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine. Neurosurgery (2000) 0.79
Sulfonamidopyrrolidinone factor Xa inhibitors: potency and selectivity enhancements via P-1 and P-4 optimization. J Med Chem (1999) 0.78
[Primary and secondary prevention of skin cancer in organ transplant recipients]. Hautarzt (2010) 0.78
Cotinine levels in Southeast Asian smokers. Nicotine Tob Res (2000) 0.78
A partially parametric estimator of survival in the presence of randomly censored data. Biometrics (1990) 0.78
Sample size to test for interaction between a specific exposure and a second risk factor in a pair-matched case-control study. Stat Med (2000) 0.78
Predictors of restful sleep in a rehabilitation hospital. Am J Phys Med Rehabil (1999) 0.78
Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption. Int J Radiat Oncol Biol Phys (1997) 0.77
Methodology reporting in three acute care journals: replication and reliability. Ann Emerg Med (1985) 0.77
Plasma atherogenic markers in congestive heart failure and posttransplant (heart) patients. J Am Coll Cardiol (2000) 0.77
Use of medians and "average of normals" of patients' data for assessment of long-term analytical stability. Clin Chem (1996) 0.77
Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7). Neurosurgery (1999) 0.77
Hemodynamic effects of oral nicorandil in congestive heart failure. Am J Cardiol (1990) 0.77
Design and structure-activity relationships of potent and selective inhibitors of blood coagulation factor Xa. J Med Chem (1999) 0.76
Methods of randomization in controlled clinical trials. Am J Emerg Med (1985) 0.76
Intra-abdominal adhesions after open and laparoscopic cholecystectomy: an experimental model. J Laparoendosc Adv Surg Tech A (2006) 0.75
Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas. Neurosurgery (2000) 0.75
Tonic accommodation, age, and refractive error in children. Invest Ophthalmol Vis Sci (1999) 0.75
Predictors of dental use for low-income, urban elderly persons upon removal of financial barriers. Gerontologist (1997) 0.75
Effects of environment and management on mortality in preweaned dairy calves. J Am Vet Med Assoc (1992) 0.75
Aminoisoquinolines: design and synthesis of an orally active benzamidine isostere for the inhibition of factor XA. Bioorg Med Chem Lett (1999) 0.75
Congenital cystic adenomatoid malformation of the lung. Prog Pediatr Surg (1987) 0.75
Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent. Radiat Res (1994) 0.75
Emergency department use of radiology services at a large urban teaching hospital. Acad Radiol (1994) 0.75
Bis(bioreductive) alkylating agents: synthesis and biological activity in a nude mouse human carcinoma model. J Med Chem (1983) 0.75
Enhanced survival in a rat glioma model following BNCT. Strahlenther Onkol (1989) 0.75
A national study of periodontal assessment by dental hygienists. J Dent Hyg (1993) 0.75
Systemic intake of fluoride and preventive dentistry. II. Fluoride physiology and vehicles. San Fernando Val Dent Soc Bull (1971) 0.75
Dental hygienists' utilization of periodontal assessment skills and perceived collaboration with dentist-employer. J Dent Hyg (1993) 0.75
Long-term results of Rehbein's procedure: a retrospective study in German-speaking countries. Eur J Pediatr Surg (2003) 0.75